Pluristem Therapeutics achieved a milestone in the build-out of its new clinical cGMP manufacturing facility for its Placental eXpanded (PLX) cells in Matam Park, Haifa, Israel. The company initiated the Installation Qualification (IQ) validation process through Biopharmax Group, which is handling the build-out of the facility. Following successful IQ, an Operation Qualification (OQ) will begin, which marks the final stage of the process. The IQ/OQ validation includes systems such as the Heating...